Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
|Videos|November 5, 2014
How to Evolve With the Changing Health Care Landscape
Thomas Cohn, chief strategy officer at Armada Health Care, discusses how Armada is changing to meet the needs of the tumultuous Affordable Care Act era.
Advertisement
Thomas Cohn, chief strategy officer at Armada Health Care, discusses how Armada is changing to meet the needs of the tumultuous Affordable Care Act era.
Advertisement
Related to this article
FDA clears tiratricol for MCT8 deficiency, lowering dangerous T3 and outlining dosing, lab testing, and pharmacy access.
AI-driven coding fuels specialty EHRs and telehealth tools, making ePrescribing faster, tailored, and affordable while shifting focus to workflow and compliance.
The once-daily tablet is the third approved treatment for fibrodysplasia ossificans progressiva (FOP), with CYP3A4 and metformin interaction guidance.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists Key to Lp(a) Counseling and Lipid Optimization
2
EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D
3
Semaglutide 2 mg Tied to Lower MACE Risk Than Tirzepatide Switch
4
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
5